After undergoing surgery, some people appear to recuperate more quickly than others. A person’s health, preexisting diseases, and heredity are all potential contributors. Even if person have a genetic predisposition to delayed healing, there are steps one may do to improve his chances of a speedier recovery. Peptides are quickly becoming one of the most talked-about and promising options available today. A peptide is a short chain of amino acids, whether they are synthesized or found in nature. They are involved in a wide variety of biochemical and physiological processes, including the healing of wounds and tissues. Due to this, peptide treatment has become more popular in the field of post-operative rehabilitation. A wide range of biological processes necessary for healing and recovery are orchestrated by peptides, which mainly function as signaling molecules in the body. To achieve this, they exert influence over several biological players, such as cells of the immune system, cytokines, and growth factors. Examples of processes that rely on growth factors include cell proliferation and differentiation, which play an essential role in tissue regeneration and wound healing.
To top it all off, peptides have an effect on cytokines, a group of proteins that are crucial for controlling inflammation. By modulating cytokine production, peptides such may alleviate postoperative inflammation and discomfort. By modulating immune system cells—those that both prevent infection and aid in tissue repair—peptides may potentially play a significant role in postoperative healing. Beyond their potential effects on inflammation and immunological regulation, peptides may also affect metabolic systems within the body.
Research has revealed that some peptides can affect protein synthesis and fat metabolism, two processes that might affect the recuperation time after surgery. For instance, improving protein synthesis might aid in the restoration of surgically injured tissues, while enhancing fat metabolism could aid in maintaining a healthy energy balance and speeding the healing process.
Peptide treatment has the potential to aid postoperative patients in several ways. Reducing inflammation and the discomfort it causes is one of the most notable advantages. Significant inflammation, which can be caused by surgery, can lead to pain, discomfort, and a slowed healing process. By controlling inflammatory reactions, peptides may alleviate postoperative pain and make recovery more bearable.
Accelerating the healing process of injured tissues is another major benefit of peptide treatment. It has been previously established that peptides can stimulate angiogenesis, the process by which new blood vessels are formed, and tissue regeneration. Because they expedite recovery by delivering oxygen and nutrients to repairing tissues, these mechanisms are essential for efficient wound healing. Immune system function is often impaired during surgery; however, peptide treatment has the potential to restore it.
In order to avoid infections after surgery and speed up the healing process, an efficient immune response is necessary. The body’s capacity to combat infections and other problems that might postpone healing could be enhanced by particular peptides that affect immune responses, as previously mentioned. And lastly, peptides have the potential to lessen scarring and other problems that could arise after surgery.
Although peptide treatment shows promise in enhancing post-operative recovery, it does come with certain restrictions and hazards. Like any treatment intervention, there is a chance that there will be adverse effects. Some individuals may have adverse reactions, nausea, or headaches after taking peptides. These adverse effects might differ significantly from one person to the next and are influenced by several factors, including as the specific peptide utilized, the dosage given, and the patient’s general condition.
In order to guarantee safety and effectiveness, peptide treatment sometimes requires customized dose and monitoring. Considerations such as the nature of the operation, general health, and preexisting diseases all play a role in determining the optimal dosage. Thus, it is imperative that anybody considering peptide therapy for post-operative recovery does so under the guidance of a medical expert who can tailor suggestions to individual needs and monitor outcomes. Additionally, there may be regulatory concerns about the usage of peptides.
Traditional treatments for obesity and T2D focus on a single receptor. One example is semaglutide, a GLP-1 receptor agonist. Furthermore, due to the fact that obesity and T2D are impacted by several pathways that control hunger, blood sugar, and energy balance, single-target treatments are ineffective.
As an example, GEP-44 binds not just the GLP-1 receptor but also the neuropeptide Y1 and Y2 receptors, making it a triple-agonist peptide. Results from studies demonstrating altered GLP-1 and peptide YY levels following bariatric surgery informed the development of the peptide. In addition to stimulating insulin secretion in pancreatic islets, GEP-44’s combined multiagonist actions include Y1-R agonism, which allows for insulin-independent glucose absorption into muscle—but only at high glucose levels. Significant weight loss and improved blood glucose management are the results of increased glucose absorption by muscle and decreases in hunger.
varied countries have varied laws regarding peptides, and certain sports may outright ban them if they are thought to be performance-enhancing drugs. On top of that, there are legitimate safety and ethical issues about the possible abuse of peptides in non-medical groups such as bodybuilders and sports.
Membrane impermeability and low in vivo stability are two primary inherent problems with peptide therapies. The length and amino acid content of peptides are two of the many variables that contribute to their limited membrane permeability. The inability of peptides to penetrate cell membranes and target intracellular organelles limits their potential use in medication discovery.
More than 90% of the peptide therapies that are currently in clinical development, target extracellular targets such gonadotropin-releasing hormone and G-protein coupled receptors. The low in vivo stability of peptides is another major obstacle. Amide bonds bind the amino acids in a natural peptide, however it is not as stable because it does not have any secondary or tertiary structures. Amide bonds are also susceptible to hydrolysis and enzymatic destruction in vivo as a result of environmental exposure. Peptides are known for their chemical and physical instability, short half-life, and rapid elimination in vivo due to these characteristics. There are several hazards associated with peptide treatment, despite its many benefits for post-operative recovery.
Forecasts indicate that the peptide drugs industry will maintain its robust growth rate in the years to come. Research into novel therapeutic uses and enhancements to peptide stability and delivery mechanisms will likely characterize future breakthroughs. Furthermore, there is a growing need to find ways to produce and synthesize peptides that are less harmful to the environment.
Peptide therapies hold enormous potential for filling unfulfilled medical requirements and offering novel treatment options for a wide range of disorders, despite ongoing obstacles, especially in areas such as oral distribution of peptides.
Ethical approval
Not applicable.
Consent
Not applicable.
Conflicts of interest disclosure
All the authors declare to have no conflicts of interest relevant to this study.
Sources of funding
All the authors declare to have received no financial support or sponsorship for this study.
Author contribution
J.P. and G.G., writing original draft and editing, and T.B.E., writing and editing and supervision.
Research registration unique identifying number (UIN)
Not applicable.
Guarantor
Talha Bin Emran.
Provenance and peer review
Not commissioned, externally peer-reviewed.
Data availability statement
Not applicable.
Acknowledgments
None.
References
[1]Wang L, Wang N, Zhang W, et al. Therapeutic peptides: current applications and future directions. Signal Transduct Target Ther 2022;7. doi:10.1038/s41392-022-00904-4.
[2]Pfalzgraff A, Brandenburg K, Weindl G. Antimicrobial peptides and their therapeutic potential for bacterial skin infections and wounds. Front Pharmacol 2018;9. doi:10.3389/fphar.2018.00281.
[3]Atakan MM, Türkel İ, Özerkliğ B, et al. Small peptides: could they have a big role in metabolism and the response to exercise? J Physiol 2024;602. doi:10.1113/JP283214.
[4]D’souza K, Mercer A, Mawhinney H, et al. Whey peptides stimulate differentiation and lipid metabolism in adipocytes and ameliorate lipotoxicity-induced insulin resistance in muscle cells. Nutrients 2020;12. doi:10.3390/nu12020425.
[5]Shi L, Zhao M, Abbey CA, et al. Newly identified peptide, peptide LV, promotes pathological angiogenesis. J Am Heart Assoc 2019;8. doi:10.1161/JAHA.119.013673.
[6]Zhao CC, Zhu L, Wu Z, et al. Resveratrol-loaded peptide-hydrogels inhibit scar formation in wound healing through suppressing inflammation. Regen Biomater 2020;7:99.
[7]Mahapatra MK, Karuppasamy M, Sahoo BM. Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes. Rev Endocr Metab Disord 2022;23. doi:10.1007/s11154-021-09699-1.
[8]Chichura KS, Elfers CT, Salameh TS, et al. A peptide triple agonist of GLP-1, neuropeptide Y1, and neuropeptide Y2 receptors promotes glycemic control and weight loss. Sci Rep 2023;13. doi:10.1038/s41598-023-36178-1.
[9]Guha S, Ghimire J, Wu E, Wimley WC. Mechanistic landscape of membrane-permeabilizing peptides. Chem Rev 2019;119. doi:10.1021/acs.chemrev.8b00520.
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.